Adipose-derived stem cells retain their regenerative potential after methotrexate treatment

Experimental Cell Research

Volumn 327, Issue 2, 2014, Pages 222-233

  Beane, Olivia S ^a   Fonseca, Vera C ^b   Darling, Eric M ^a,b,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c Brown University   (United States)

Author keywords

Bone; Cell transplantation; Chemotherapy; Mesenchymal stem cell; Tissue regeneration

Indexed keywords

CYTARABINE; DIHYDROFOLATE REDUCTASE; ETOPOSIDE; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC ANTIMETABOLITE;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; BONE DEVELOPMENT; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL DIVISION; CELL EXPANSION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CELL VIABILITY; CHONDROGENESIS; CLONOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EXPOSURE; FEMALE; FIBROBLAST; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; NEWBORN; NORMAL HUMAN; SENESCENCE; SPECTROPHOTOMETRY; STAINING; STROMA CELL; STROMAL VASCULAR FRACTION CELL; TISSUE REGENERATION; UPREGULATION; ADIPOSE TISSUE; ADOLESCENT; BONE; CELL CULTURE; CELL TRANSPLANTATION; CHEMOTHERAPY; CYTOLOGY; DRUG EFFECT; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; MULTIPOTENT STEM CELL; WESTERN BLOTTING; YOUNG ADULT;

BONE; CELL TRANSPLANTATION; CHEMOTHERAPY; MESENCHYMAL STEM CELL; TISSUE REGENERATION;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; HUMANS; METHOTREXATE; MIDDLE AGED; MULTIPOTENT STEM CELLS; STROMAL CELLS; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 84907684229     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.06.015     Document Type: Article

References (42)

1. Anderson L.L., Collins G.J., Ojima Y., Sullivan R.D. A study of the distribution of methotrexate in human tissues and tumors. Cancer Res. 1970, 30:1344-1348.
2. Awad H.A., Halvorsen Y.D., Gimble J.M., Guilak F. Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Tissue Eng. 2003, 9:1301-1312.
3. Behan J.W., Avramis V.I., Yun J.P., Louie S.G., Mittelman S.D. Diet-induced obesity alters vincristine pharmacokinetics in blood and tissues of mice. Pharmacol. Res. 2010, 61:385-390.
4. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J., Golland P., Sabatini D.M. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006, 7:R100.
5. Cowman A.F., Foote S.J. Chemotherapy and drug-resistance in malaria. Int. J. Parasitol. 1990, 20:503-513.
6. Cronstein B.N. The mechanism of action of methotrexate. Rheum. Dis. Clin. N. Am. 1997, 23:739.
7. Ertas G., Ural E., Ural D., Aksoy A., Kozdag G., Gacar G., Karaoz E. Comparative analysis of apoptotic resistance of mesenchymal stem cells isolated from human bone marrow and adipose tissue. Sci. World J. 2012, 2012:105698.
8. Estes B.T., Diekman B.O., Gimble J.M., Guilak F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat. Protoc. 2010, 5:1294-1311.
9. Estes B.T., Diekman B.O., Guilak F. Monolayer cell expansion conditions affect the chondrogenic potential of adipose-derived stem cells. Biotechnol Bioeng. 2008, 99:986-995.
10. Estes R.T., Wu A.W., Storms R.W., Guilak F. Extended passaging, but not aldehyde dehydrogenase activity, increases the chondrogenic potential of human adipose-derived adult stem cells. J. Cell. Physiol. 2006, 209:987-995.
11. Fagman H., Larsson F., Arvidsson Y., Meuller J., Nordling M., Martinsson T., Helmbrecht K., Brabant G., Nilsson M. Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation. Oncogene 2003, 22:6013-6022.
12. Gardner R.V., Lerner C., Astle C.M., Harrison D.E. Assessing permanent damage to primitive hematopoietic stem-cells after chemotherapy using the competitive repopulation assay. Cancer Chemother. Pharmacol. 1993, 32:450-454.
13. George P., Journey L.J., Goldstein M.N. Effect of vincristine on the fine structure of HeLa cells during mitosis. J. Natl. Cancer Inst. 1965, 35:355-375.
14. Georgiou K.R., Scherer M.A., Fan C.M., Cool J.C., King T.J., Foster B.K., Xian C.J. Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow. J. Cell. Physiol. 2012, 227:909-918.
15. Goldman I.D., Matherly L.H. The cellular pharmacology of methotrexate. Pharmacol. Ther. 1985, 28:77-102.
16. Gonzalez-Cruz R.D., Fonseca V.C., Darling E.M. Cellular mechanical properties reflect the differentiation potential of adipose-derived mesenchymal stem cells. Proc. Natl. Acad. Sci. U.S.A 2012, 109:E1523-E1529.
17. Guilak F., Lott K.E., Awad H.A., Cao Q., Hicok K.C., Fermor B., Gimble J.M. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J. Cell. Physiol. 2006, 206:229-237.
18. Guo W., Healey J.H., Meyers P.A., Ladanyi M., Huvos A.G., Bertino J.R., Gorlick R. Mechanisms of methotrexate resistance in osteosarcoma. Clin. Cancer Res. 1999, 5:621-627.
19. Hattangadi D.K., DeMasters G.A., Walker T.D., Jones K.R., Di X., Newsham I.F., Gewirtz D.A. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem. Pharmacol. 2004, 68:1699-1708.
20. Kearney P.J., Light P.A., Preece A., Mott M.G. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother. Pharmacol. 1979, 3:117-120.
21. Li J., Law H.K., Lau Y.L., Chan G.C. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br. J. Haematol. 2004, 127:326-334.
22. Li J.C., Kaminskas E. Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc. Natl. Acad. Sci. U.S.A 1984, 81:5694-5698.
23. Liang W., Xia H., Li J., Zhao R.C. Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents. Cytotechnology 2011, 63:523-530.
24. Lv F.J., Tuan R.S., Cheung K.M., Leung V.Y. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 2014, 32:1408-1419.
25. Mandel K., Atkinson S., Barr R.D., Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 2004, 22:1215-1221.
26. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., Di Halvorsen Y., Storms R.W., Goh B., Kilroy G., Wu X., Gimble J.M. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
27. Qi Z., Zhang Y.M., Liu L., Guo X., Qin J., Cui G.H. Mesenchymal stem cells derived from different origins have unique sensitivities to different chemotherapeutic agents. Cell Biol. Int. 2012, 36:857-862.
28. Ross D.D., Chen S.R., Cuddy D.P. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution. Cancer Res. 1990, 50:2658-2666.
29. Ross W., Rowe T., Glisson B., Yalowich J., Liu L. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 1984, 44:5857-5860.
30. Schellenberg A., Lin Q., Schuler H., Koch C.M., Joussen S., Denecke B., Walenda G., Pallua N., Suschek C.V., Zenke M., Wagner W. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging-Us 2011, 3:873-888.
31. Schriock E.A., Schell M.J., Carter M., Hustu O., Ochs J.J. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J. Clin. Oncol. 1991, 9:400-405.
32. Severino J., Allen R.G., Balin S., Balin A., Cristofalo V.J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp. Cell Res. 2000, 257:162-171.
33. Suga H., Matsumoto D., Eto H., Inoue K., Aoi N., Kato H., Araki J., Yoshimura K. Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev. 2009, 18:1201-1210.
34. Sun S.N., Gui Y.H., Jiang Q., Song H.Y. Dihydrofolate reductase is required for the development of heart and outflow tract in zebrafish. Acta Biochim. Et Biophys. Sin. 2011, 43:957-969.
35. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., Tallquist M.D., Graff J.M. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322:583-586.
36. Wall A.M., Rubnitz J.E. Pharmacogenomic effects on therapy for acute lymphoblastic leukemia in children. Pharmacogen.J. 2003, 3:128-135.
37. Yoon S.A., Choi J.R., Kim J.O., Shin J.Y., Zhang X., Kang J.H. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity. Cancer Res. Treat. 2010, 42:163-171.
38. Yoshimura K., Shigeura T., Matsumoto D., Sato T., Takaki Y., Aiba-Kojima E., Sato K., Inoue K., Nagase T., Koshima I., Gonda K. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J. Cell. Physiol. 2006, 208:64-76.
39. Youssef J., Nurse A.K., Freund L.B., Morgan J.R. Quantification of the forces driving self-assembly of three-dimensional microtissues. Proc. Natl. Acad. Sci. U.S.A 2011, 108:6993-6998.
40. Zhao Y., Waldman S.D., Flynn L.E. The effect of serial passaging on the proliferation and differentiation of bovine adipose-derived stem cells. Cells Tissues Organs. 2012, 195:414-427.
41. Zheng B., Cao B., Li G., Huard J. Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tissue Eng. 2006, 12:1891-1901.
42. Zimmerlin L., Donnenberg A.D., Rubin J.P., Basse P., Landreneau R.J., Donnenberg V.S. Regenerative therapy and cancer: in vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng. Part A 2011, 17:93-106.